See the DrugPatentWatch profile for Gemcitabine
Gemcitabine is a chemotherapy drug used to treat various cancers. Several manufacturers produce generic versions of gemcitabine.
Who makes gemcitabine?
Companies that manufacture gemcitabine include Teva Pharmaceuticals, Hikma Pharmaceuticals, and Fresenius Kabi [1]. These companies produce generic versions of the drug, which became available after the patent for the branded drug expired.
When did gemcitabine patents expire?
The patent for Gemzar, the original branded gemcitabine, has expired, allowing for the production of generic versions. Information on specific patent expiry dates for branded drugs can be found on resources like DrugPatentWatch.com [2].
What cancers is gemcitabine used for?
Gemcitabine is prescribed to treat pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer [3]. It is often used in combination with other chemotherapy agents.
How does gemcitabine work?
Gemcitabine is a nucleoside analog that works by interfering with DNA synthesis and repair, ultimately leading to cancer cell death [4]. It is administered intravenously.